Evidence Hub

Mapping ICD-10 to ICCC-3 for Childhood Cancer Classification Using Cancer Incidence in Five Continents (CI5) Data

Liu J, Sun X, Sun M, Yang H

2026

Abstract

Abstract Background Global childhood and adolescent cancer burden estimation is limited by inconsistent diagnostic classification systems. ICCC‑3 is the benchmark for pediatric cancer research, but large registries mainly use ICD‑10, which cannot be directly matched to ICCC‑3. A unified mapping framework is required to accurately quantify disease burden and enable cross‑database data comparison. Methods We used pediatric cancer incidence data from the US registries in CI5 Volume XII, which provides dual coding in ICD-10 and ICCC-3. We developed a three-tier ICD-10 to ICCC-3 mapping strategy: (1) direct mapping to main diagnostic groups; (2) subgroup mapping for lymphoid and hematopoietic neoplasms; and (3) manual mapping for the other subgroups. Results We identified 77,236 pediatric cancer cases coded in ICD-10 and 77,152 cases coded in ICCC-3. Near-perfect concordance (CR ≈ 1.00) was observed for retinoblastoma, brain and CNS tumors, renal tumors, and hepatic tumors. Over-mapping was noted for epithelial neoplasms/melanomas (CR = 1.24), bone tumors (CR = 1.11), and leukemias (CR = 1.07), while under-mapping occurred for neuroblastomas (CR = 0.67), germ cell tumors (CR = 0.72), soft tissue sarcomas (CR = 0.87), lymphomas (CR = 0.88), and unspecified malignant neoplasms (CR = 0.47). For lymphoid and hematopoietic neoplasms, an ICD-O-3–mediated crosswalk enabled subgroup mapping with enhanced specificity. However, for most other subgroups, precise one-to-one mapping was not…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free